Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read moreTag: Biotechnology Services
Rivian and 7 More Clean Energy Stocks Citi Says Could Drop Even More
Text size Rivian Automotive saw its cash and cash equivalents decline by $6.6 billion last year. ...
Read more
SolarEdge Stock Tumbles After Weak Guidance. Why Analysts Are Still Upbeat.
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to ...
Read more
Nvidia, AMD, AeroVironment, Micron, and More Stock Market Movers
Text size A report said the Commerce Department could stop the shipments of artificial intelligence chips ...
Read more
Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Read more
Carl Icahn and Illumina Proxy Fight Consequence: CEO Survives, Chairman Is Out
Activist investor Carl Icahn needs a gain at Illumina just after a string of issues elsewhere. ...
Read more
Horizon Therapeutics Stock Plunges on Experiences FTC Will Sue to Block Amgen Offer
Textual content dimension Amgen had aid it envisioned its acquisition of Horizon Therapeutics to be finished ...
Read more
Healthcare Stocks Are on Sale. Pfizer and Stryker Have Potent Growth Potential customers.
Health care Stocks Are on Sale. Pfizer and Stryker Have Sturdy Progress Prospective buyers.
Read more
Prometheus, Merck, Moderna, Charles Schwab, XPeng, and Far more Inventory Market Movers
Text dimension Merck agreed to buy Prometheus Biosciences for about $10.8 billion. Michael Vi/Dreamstime Inventory futures ...
Read more
Merck to Acquire Prometheus Biosciences
Merck to Purchase Prometheus Biosciences
Read more